Navigation Links
Echo Therapeutics Receives Frost & Sullivan's 2011 Technology Innovation Award
Date:3/1/2011

FRANKLIN, Mass., March 1, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it won the prestigious 2011 North American Frost & Sullivan Technology Innovation Award in Pharmaceuticals and Biotechnology.  Echo received this award in recognition of the Prelude SkinPrep System's breakthrough technology.

The Prelude SkinPrep System uses a needle-free, painless technology that removes the outermost layer of skin, the stratum corneum, to permit topical drug delivery or needle-free analyte analysis.  For its initial use, Echo's partner, Ferndale Pharma Group, has applied to the U.S. Food and Drug Administration for permission to market the Prelude SkinPrep System to enhance the delivery of topical 4% lidocaine.  

Echo is now accelerating the final Prelude manufacturing validation and scale-up in order to prepare for commercial launch and it expects marketing efforts of the Prelude SkinPrep System to commence in the third quarter of this year, pending FDA approval.  The FDA 510(k)submission was supported by clinical data from a study that demonstrated skin anesthesia with 4% lidocaine was achieved within five minutes following use of the Prelude System, compared to the customary 30-to-60-minute wait.

"We are pleased that Frost & Sullivan has recognized the significance of Echo's Prelude SkinPrep technology in drug delivery," said Echo's Chairman and CEO Patrick T. Mooney, M.D.  "We believe that 2011 will be a transformative year for Echo and our shareholders and we feel that this recognition is well-deserved and demonstrates the value of our technology."

The Frost & Sullivan Award
'/>"/>

SOURCE Echo Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Proxy Statement, Schedule 14A, with the U.S. Securities & Exchange ... shareholders detailing why a "YES" vote to increase the number ... As we reflect upon the 2014 fiscal year that ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... and development company, is delighted to announce that the ... to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for the ...
(Date:1/22/2015)... DIEGO, Jan. 22, 2015  ResMed Inc. (NYSE: RMD ... 2014. Revenue for the quarter was $423.0 million, a 10 ... (a 14 percent increase on a constant currency basis). Net ... to the quarter ended December 31, 2013. Diluted earnings per ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... Corp. / surgicalinstruments.com has developed an online ... who perform surgical instrument reprocessing for hospitals and ... pictures and descriptions of a large selection of ... rigid endoscopes, and accessories including video camera heads, ...
... Corporation ("CompCare") (OTC BB: CHCR), a leading behavioral health, ... managed care companies throughout the U.S., today announced that ... March 31, 2012 totaled $17,890,000.  Net income totaled $80,000 ... to announce that CompCare achieved a profit, albeit modest, ...
Cached Medicine Technology:Millennium Surgical Corp. Develops Online Sterilization Resource Center 2Comprehensive Care Corporation Announces Profit for First Quarter 2Comprehensive Care Corporation Announces Profit for First Quarter 3
(Date:1/22/2015)... 22, 2015 The federal court overseeing thousands ... District Court, Southern District of West Virginia has upheld a ... proceeding’s first bellwether trial. In an Order dated January 21st, ... after finding that C.R. Bard had not proven a miscarriage ...
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... January 23, 2015 Recently, Weddingshe.com has added ... and has announced its highest annual revenues in the past ... its popular glamorous wedding dresses. , According to the sales ... wedding dress promotions for them in 2015. This point can ...
(Date:1/22/2015)... As interest in the value of spiritual support ... Rev. Eric J. Hall , president and CEO of ... be the keynote speaker on January 27 at an international ... , The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual ...
(Date:1/22/2015)... State Forestry Institute of Mecklenburg-Vorpommern in ... support from GEOSYSTEMS, a dedicated Hexagon Geospatial and Intergraph ... Hexagon Geospatial’s ERDAS APOLLO for cataloging, managing, ... point clouds and documents. This effort will enable the ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... ... management organization, is pleased to announce the donation of $12,260 to the Cystic Fibrosis ... Harrisburg, ... ), a leading quality improvement and care management organization, is pleased to announce the ...
... , , , WHO: Community ... directors, nurses and other community oncology staff, WHAT: ... Technology (HIT) stimulus:, ... records (EHR), ...
... Leaders Amplifies "United We Serve" , , WASHINGTON, June ... a summer of service, U.S. Agency for International Development (USAID) ... in Baltimore for the inauguration of President Obama,s "United We ... and be a part of building a new foundation for ...
... Maximizes Biocompatibility and Biostabilityin a Bare-Metal Stent , ... announced that it has received CE mark approval for ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20070206/CLTU213LOGO ... a next-generation cobalt-chromium bare-metal stent. Utilizing a novel ion-based ...
... experience a lower rate of adverse reactions on automated 2-unit ... ZURICH, Ill., June 23 Fenwal Inc. announced today it ... M.D., Ph.D., chief medical officer of the American Red Cross, ... automated two-unit red cell procedures and manual whole blood collection ...
... BERNARDSVILLE, N.J., June 23 Protocol Driven Healthcare, Inc. ... (HRA) Data-Load Process so that organizations can merge historical ... ConXus Profile HRA. , , Organizations may be ... new vendor for fear of losing valuable health information ...
Cached Medicine News:Health News:KePRO Employees Make "Great Strides" Towards Cure for Cystic Fibrosis 2Health News:KePRO Employees Make "Great Strides" Towards Cure for Cystic Fibrosis 3Health News:US Oncology Offers Electronic Health Records Informative Webinar 2Health News:US Oncology Offers Electronic Health Records Informative Webinar 3Health News:USAID Brings White House Service Initiative to Baltimore 2Health News:USAID Brings White House Service Initiative to Baltimore 3Health News:CorNova(R) Receives CE Mark Approval for Valecor Platinum(R) Coronary Stent System 2Health News:Fenwal to Host Webinar on the Safety of 2-Unit Red Cell Collections From Young Donors 2Health News:Fenwal to Host Webinar on the Safety of 2-Unit Red Cell Collections From Young Donors 3Health News:PDHI Launches ConXus Profile Third-Party Health Risk Assessment Data-Load Process 2
The Precedent establishes a new generation of revision hip stems....
Calcar replacement stems provide options for revision and trochanteric fractures. Revision hip surgery and trauma often require prosthetic designs that replace proximal medial calcar bone loss....
...
...
Medicine Products: